Decreased Adiponectin Levels in Polycystic Ovary Syndrome, Independent of Body Mass Index
- 1 February 2010
- journal article
- research article
- Published by SAGE Publications in Metabolic Syndrome and Related Disorders
- Vol. 8 (1) , 47-52
Abstract
Background: Insulin resistance has been shown to have an association with polycystic ovary syndrome (PCOS). This study was designed to evaluate the potential role of adiponectin, which is linked with insulin resistance, in the etiology of PCOS and its relationship to obesity. Methods: This case–control study consisted of 103 newly diagnosed PCOS cases and 73 female controls seen at a referral university hospital in Zanjan, Iran. Serum adiponectin, insulin, plasma fasting glucose, and lipid levels were measured. The homeostasis model assessment index was used to determine the level of insulin resistance. Women were classified as follows: Group I (normal nonlean women); group II (normal lean women); group III (nonlean women with PCOS); and group IV (lean women with PCOS) Results: Adiponectin levels were decreased in women with PCOS (8.4 ± 2.7 ng/mL vs. 13.6 ± 5 ng/mL in the control group, P < 0.001). There was no significant difference between the adiponectin concentrations of women in group III and that in group IV (8.1 ± 2.8 ng/mL vs. 9.2 ± 2.6 ng/mL, respectively, P = 0.1). Adiponectin levels were significantly lower in group I compared with group II. A weak but significant negative correlation was found between adiponectin and insulin levels in all the subjects. Multiple regression analyses showed that the presence of PCOS was the only significant determinant of serum adiponectin levels. Conclusions: Adiponectin levels were reduced in all the women with PCOS. There seemed to be an interaction between adiponectin and PCOS pathogenesis that was independent of body mass index.Keywords
This publication has 34 references indexed in Scilit:
- Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic TherapyDiabetes, 2003
- Signals of adiposityDomestic Animal Endocrinology, 2001
- The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesityNature Medicine, 2001
- The adipocyte-secreted protein Acrp30 enhances hepatic insulin actionNature Medicine, 2001
- Circulating Concentrations of the Adipocyte Protein Adiponectin Are Decreased in Parallel With Reduced Insulin Sensitivity During the Progression to Type 2 Diabetes in Rhesus MonkeysDiabetes, 2001
- Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance and HyperinsulinemiaThe Journal of Clinical Endocrinology & Metabolism, 2001
- Adipose Tissue as an Endocrine OrganTrends in Endocrinology & Metabolism, 2000
- An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular WallsHormone and Metabolic Research, 2000
- Novel Modulator for Endothelial Adhesion MoleculesCirculation, 1999
- A Novel Serum Protein Similar to C1q, Produced Exclusively in AdipocytesJournal of Biological Chemistry, 1995